Urinary Urge Incontinence
29
5
6
13
Key Insights
Highlights
Success Rate
68% trial completion
Published Results
12 trials with published results (41%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
20.7%
6 terminated out of 29 trials
68.4%
-18.1% vs benchmark
21%
6 trials in Phase 3/4
92%
12 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (29)
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
Study of 30-Minute Stimulation With the Neuspera Sacral Neuromodulation (SNM) System
FREEDOM Registry - Follow up Revision Experience and Evaluation of Device Outcomes Metrics
Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
RESTORE: An RCT to Evaluate the Efficacy of the Revi System
INvestigation of TENS Efficacy Versus Posterior Tibial Nerve Stimulation for Overactive Bladder
Pivotal Study of eCoin for Overactive Bladder With Urgency Urinary Incontinence
Axonics SacRal NeuromodulaTIon System RegisTRY Study
Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized Trial
Efficacy of Vaginal 17β-Estradiol on the Urinary Storage Symptoms in Postmenopausal Women
Cycling Study With the Axonics System
Real-World Registry - The Vivally® System
A Sham-Controlled Study to Evaluate the Safety and Efficacy of a Smart, Self-Adjusting, Surgery-Free, Wearable Bladder Neuromodulation System for Overactive Bladder
Bladder Diary for Female Storage LUTS
PTNS on Urinary and Global Quality of Life in MS Patients
The Effects of Sacral Neuromodulation for Urinary Urgency, Frequency, and Urge Incontinence
eCoin for OAB Feasibility Follow-on Study
InterStim Basic Evaluation Lead Post-Market Clinical Follow-up Study
InterStim® Amplitude Study